index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Anti-IgE IgG Biomarkers COVID-19 Myositis Agalsidase Auto-antibodies Assisted communication devices Prognosis Anti-interleukin-6 Anti-drug antibodies Myopathy Active Auto-immunité Amyotrophic lateral sclerosis Anti-agalsidase antibodies Anticorps anti-agalsidase Lysosomal storage diseases Autoantibodies Adolescence Fabry disease Humans Interstitial lung disease Sphingosine-1-phosphate Multidisciplinarity Myositis and muscle disease AAV humoral immunity AAV vector Antiphospholipid syndrome Myocarditis Aldosterone Interferon Outcome measures Anti‐mitochondrial antibodies Acute Kidney Injury/epidemiology/etiology Systems biology AAV antibody Inflammation Inflammatory myopathy Autoantibody Immune checkpoint inhibitors Gene therapy B-lymphocyte Male Adult AAV Dependovirus/genetics/immunology Polymyositis Adeno-associated vector IMNM Antibody responses Antisynthétase Anti-Mi2 Biopsy AAV vectors Adverse drug reactions Anémie hémolytique Auto‐antibodies Anti-synthetase syndrome Pharmacology DM Female Antisynthetase syndrome Biomarker Anticorps spécifique des myosites Adjudication Acid-alpha-glucosidase Adeno-associated virus Abnormal movement Aldostérone B cell homeostasis Inclusion body myositis Analyses multidimensionnelles Arthritis Cytokines Deep immune profiling Mass cytometry Animals Autoimmune diseases Dermatomyositis Immunotherapy Idiopathic inflammatory myopathies Aged Biomarqueurs Amyotrophy Middle Aged Anti-MDA5 autoantibodies Antisynthetase Adeno-associated virus vector Skeletal muscle Inborn errors of metabolism Cancer IBM Autoimmunity Data integration Bioelectrical impedance analysis Machine learning Cardio-oncology Antibodies Case reports Muscle